Indication
Hypertensive disorders in pregnancy
6 clinical trials
8 products
Clinical trial
Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-05-01
Product
LabetalolProduct
NIFEdipineClinical trial
A Randomized Controlled Trial of Pravastatin to Prevent Preeclampsia in High Risk WomenStatus: Active (not recruiting), Estimated PCD: 2026-06-01
Product
PravastatinClinical trial
Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida: An Open Label, Comparative Effectiveness, Randomized Controlled Trial (ASPREO Trial)Status: Completed, Estimated PCD: 2023-04-10
Product
AspirinClinical trial
Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension: A Comparative Effectiveness Pilot Randomized Controlled TrialStatus: Active (not recruiting), Estimated PCD: 2022-06-26
Product
ACE Inhibitors + DiureticsProduct
Nifedipine ERClinical trial
Pilot Treatment of Persistent Non-Severe Postpartum HypertensionStatus: Terminated, Estimated PCD: 2021-02-12
Product
NifedipineClinical trial
The Differences in Adverse Maternal and Fetal Outcomes Related to Hypertension in Obese Versus Non-obese Pregnant WomenStatus: Not yet recruiting, Estimated PCD: 2026-04-01
Product
Anti-Hypertensive